|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1212 New York Ave., NW, Suite 800 |
Address2 |
|
City | Washington |
State | DC |
Zip Code | 20005 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 1262-12
|
||||||||
|
6. House ID# 305260000
|
TYPE OF REPORT | 8. Year | 2017 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Annetha Hall |
Date | 8/28/2017 4:43:56 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
P.L. 111-375 National Alzheimer's Project Act, All Sections
S.311/H.R.2972 Alzheimer's Caregiver Support Act
H.R. 1676/S. 693 The Palliative Care and Hospice Education and Training Act
S. Res 49 A resolution declaring that achieving the primary goal of the National Plan to Address Alzheimer's Disease of the Department of Health and Human Services to prevent and effectively treat Alzheimer's disease by 2025 is an urgent national priority
S. 464 the Independence at Home Act of 2016
S. 178 the Elder Abuse Prevention and Prosecution Act
S. 547 Senior Financial Empowerment Act of 2017
H.R.2953 Preventive Health Savings Act
H.R.2430/S.934 FDA Reauthorization Act of 2017
S.1028 RAISE Family Caregivers Act
H.R.2505/S.1151 Credit for Caring Act
H.R.2797/S.1334 Patient Choice and Quality Care Act
H.R.2973 Alzheimer's Disease Semipostal Stamp Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), Centers For Medicare and Medicaid Services (CMS), Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rachel |
Conant |
|
|
|
Sarah |
Smith |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
National Institutes of Health, Alzheimer's Disease, and the Cures Acceleration Network
P.L. 112-25 Budget Control Act of 2011, provisions related to funding for nondefense discretionary programs; entitlements reform
The fiscal year 2017 Labor, Health & Human Services, Education and Related Agencies Appropriations Bill, All sections related to the National Institutes of Health, Alzheimer's Disease and the Cures Acceleration Network
The fiscal year 2018 Labor, Health & Human Services, Education and Related Agencies Appropriations Bill, All sections related to the National Institutes of Health, Alzheimer's Disease and the Cures Acceleration Network
Fiscal Year 2017 Agriculture Appropriations Bill, All sections related to the Food and Drug Administration
Fiscal Year 2018 Agriculture Appropriations Bill, All sections related to the Food and Drug Administration
Fiscal Year 2017 Defense Appropriations Bill
Fiscal Year 2018 Defense Appropriations Bill
Fiscal Year 2017 Interior and Environment Appropriations Bill
Fiscal Year 2018 Interior and Environment Appropriations Bill
Fiscal Year 2017 Military Construction, Veterans Affairs and Related Agencies Appropriations Bill
Fiscal Year 2018 Military Construction, Veterans Affairs and Related Agencies Appropriations Bill
H.R.244, Consolidated Appropriations Act 2017 Division A - Agriculture and FDA, Division G - Interior and Environment, Division H - Labor, HHS and Education
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rachel |
Conant |
|
|
|
Sarah |
Smith |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
Food and Drug Administration Reauthorization Act of 2017
H.R.2973 Alzheimer's Disease Semipostal Stamp Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA), Natl Institutes of Health (NIH)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rachel |
Conant |
|
|
|
Sarah |
Smith |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |